The Magazine of Corporate Responsibility

Recent Stories rss

Drug Industry Lobbyists and Campaign Cash Stymie Bid to Restrain Medicare Prescription Costs(0)

October 18, 2016

When Congress approved the landmark Medicare Part D program in 2003 to help seniors buy prescription drugs, it slapped on an unusual restriction: The federal government was barred from negotiating cheaper prices for those medicines. The ban on government price bargaining, justified by supporters on free market grounds, has been derided by critics as a giant gift to the drug industry.

Full Story»

Conflict Minerals and Firms’ Ignorance Over Their Supply Chains

Since the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, American law has required publicly traded companies to detail their sources of so-called “conflict minerals.. Academic research finds that almost 80 percent of firms were unable to determine the sources of the minerals in their products while only one percent could certify their products free of conflict minerals “with great certainty.”

Amazon Says It Puts Customers First. But Its Pricing Algorithm Doesn’t.

Amazon often says it seeks to be “Earth’s most customer-centric company.” Jeffrey P. Bezos, its founder and CEO, has been known to put an empty chair in meetings to remind employees of the need to focus on the customer. But in fact, the company appears to be using its market power and proprietary algorithm to advantage itself at the expense of sellers and many customers.

One Man’s Leadership Toward a Goal: ‘The Great Mission of Business Ethics’

Columnist Gael O’Brien examines the achievements and contributions of a man – W. Michael Hoffman (pictured left) – and the Center for Business Ethics at Bentley University, which he founded 40 years ago. “Legacy goes beyond a name on a building,” O’Brien writes. “It’s the sustained passion that connects with and energizes the passion of others sharing a mission.”

More in this category